spiradoline has been researched along with mr 2266 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohno, M; Ueki, S; Yamamoto, T | 1 |
| Shimada, Y; Yamada, K; Yoshida, S | 1 |
| Hamon, G; Jouquey, S | 1 |
| Nakano, M; Yamada, K; Yoshida, S | 1 |
| Imai, M; Yamada, K; Yoshida, S | 1 |
| Shibata, S; Tominaga, K; Watanabe, S | 1 |
1 review(s) available for spiradoline and mr 2266
| Article | Year |
|---|---|
Kappa agonists and vasopressin secretion.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzomorphans; Diuretics; Paraventricular Hypothalamic Nucleus; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Supraoptic Nucleus; Vasopressins | 1990 |
5 other study(ies) available for spiradoline and mr 2266
| Article | Year |
|---|---|
Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.
Topics: Analgesics; Animals; Benzomorphans; Cues; Discrimination, Psychological; Dopamine; Dopamine Antagonists; Dynorphins; Male; Morphine; Narcotic Antagonists; Peptide Fragments; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1992 |
Atrial natriuretic polypeptide secretion via selective activation of kappa-opioid receptor: role of dynorphin.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Animals, Newborn; Atrial Natriuretic Factor; Benzomorphans; Cells, Cultured; Diuretics; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalin, Methionine; Enkephalins; Heart; Heart Atria; Kinetics; Naloxone; Narcotic Antagonists; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa | 1991 |
Inhibition of elevated arginine vasopressin secretion in response to osmotic stimulation and acute haemorrhage by U-62066E, a kappa-opioid receptor agonist.
Topics: Acute Disease; Analgesics; Animals; Arginine Vasopressin; Benzomorphans; Blood Pressure; Dose-Response Relationship, Drug; Hemorrhage; Hypertonic Solutions; Iodine Radioisotopes; Medulla Oblongata; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa | 1990 |
Mechanism of diuretic action of U-62,066E, a kappa opioid receptor agonist.
Topics: Animals; Arginine Vasopressin; Benzomorphans; Diuretics; In Vitro Techniques; Kidney Tubules, Collecting; Male; Narcotic Antagonists; Natriuresis; Osmolar Concentration; Pyrrolidines; Rats; Rats, Inbred BB; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa | 1989 |
kappa-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzomorphans; Brain Ischemia; Deoxyglucose; Drug Tolerance; Hippocampus; Hypoglycemia; Hypoxia, Brain; In Vitro Techniques; Male; Morphine; Naloxone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1995 |